Editorial: (Pharmaco)Metabolomics in Drug Discovery and Individualisation of Treatment

Curr Pharm Des. 2017;23(14):2027. doi: 10.2174/1381612823999170301112648.
No abstract available

Keywords: (Pharma)cometabolomics; biomarker discovery; drug discovery; pharmacogenetics; precision medicince; respiratory medicine.

Publication types

  • Editorial
  • Introductory Journal Article

MeSH terms

  • Cytochrome P450 Family 4 / antagonists & inhibitors
  • Cytochrome P450 Family 4 / genetics
  • Cytochrome P450 Family 4 / metabolism
  • Drug Discovery*
  • Humans
  • Lung Diseases / drug therapy*
  • Lung Diseases / genetics
  • Lung Diseases / metabolism
  • Metabolomics*
  • Neoplasms / drug therapy*
  • Neoplasms / genetics
  • Neoplasms / metabolism
  • Pharmacogenetics*
  • Precision Medicine*

Substances

  • CYP4Z1 protein, human
  • Cytochrome P450 Family 4